Gaurav Syal

1.0k total citations
50 papers, 446 citations indexed

About

Gaurav Syal is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Gaurav Syal has authored 50 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 26 papers in Epidemiology and 18 papers in Surgery. Recurrent topics in Gaurav Syal's work include Inflammatory Bowel Disease (36 papers), Microscopic Colitis (24 papers) and Autoimmune and Inflammatory Disorders (7 papers). Gaurav Syal is often cited by papers focused on Inflammatory Bowel Disease (36 papers), Microscopic Colitis (24 papers) and Autoimmune and Inflammatory Disorders (7 papers). Gaurav Syal collaborates with scholars based in United States, Canada and Netherlands. Gaurav Syal's co-authors include Jonathan A. Dranoff, Michel Fausther, Edward L. Barnes, Laura E. Raffals, Parakkal Deepak, Poonam Beniwal‐Patel, George P. Christophi, Christina Ha, Hans Herfarth and Stephen B. Hicks and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and The American Journal of Gastroenterology.

In The Last Decade

Gaurav Syal

46 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaurav Syal United States 11 289 247 172 62 61 50 446
Aušrinė Barakauskienė Lithuania 9 335 1.2× 314 1.3× 199 1.2× 74 1.2× 54 0.9× 15 557
Timothy E. Ritter United States 11 279 1.0× 215 0.9× 110 0.6× 41 0.7× 31 0.5× 38 442
Félix Goutorbe France 14 549 1.9× 428 1.7× 321 1.9× 45 0.7× 24 0.4× 21 641
Evanthia Zampeli Greece 9 181 0.6× 140 0.6× 122 0.7× 39 0.6× 20 0.3× 26 379
David J. Tsoulis Canada 7 563 1.9× 437 1.8× 144 0.8× 38 0.6× 27 0.4× 9 661
Henna Rautiainen Finland 8 272 0.9× 413 1.7× 254 1.5× 47 0.8× 215 3.5× 8 539
Jill Fennell United Kingdom 4 455 1.6× 360 1.5× 192 1.1× 34 0.5× 32 0.5× 5 534
R. Cosintino Italy 11 361 1.2× 276 1.1× 142 0.8× 44 0.7× 32 0.5× 17 409
G. Van Assche Belgium 6 506 1.8× 340 1.4× 337 2.0× 35 0.6× 19 0.3× 6 657
P. Rutgeerts Belgium 8 291 1.0× 225 0.9× 172 1.0× 53 0.9× 17 0.3× 10 461

Countries citing papers authored by Gaurav Syal

Since Specialization
Citations

This map shows the geographic impact of Gaurav Syal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaurav Syal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaurav Syal more than expected).

Fields of papers citing papers by Gaurav Syal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaurav Syal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaurav Syal. The network helps show where Gaurav Syal may publish in the future.

Co-authorship network of co-authors of Gaurav Syal

This figure shows the co-authorship network connecting the top 25 collaborators of Gaurav Syal. A scholar is included among the top collaborators of Gaurav Syal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaurav Syal. Gaurav Syal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Syal, Gaurav, et al.. (2025). Biomarkers for Disease Activity in Inflammatory Bowel Disease. Gastroenterology Clinics of North America. 55(1). 107–123.
2.
Scott, Frank I., Ashwin N. Ananthakrishnan, Benjamin Click, et al.. (2025). AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn’s Disease. Gastroenterology. 169(7). 1397–1448. 1 indexed citations
3.
Singh, Siddharth, M. Hassan Murad, Yuhong Yuan, et al.. (2025). Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn’s Disease: 2025 AGA Evidence Synthesis. Gastroenterology. 169(7). 1516–1536. 2 indexed citations
4.
Yuan, Yuhong, Christopher Ma, Brigid S. Boland, et al.. (2025). IL-23p19 Antagonists vs Ustekinumab for Treatment of Crohn's Disease: A Meta-Analysis of Randomized Controlled Trials. The American Journal of Gastroenterology. 120(10). 2260–2267. 2 indexed citations
5.
Syal, Gaurav, Brigid S. Boland, John T. Chang, et al.. (2024). Impact of Treatment Response on Risk of Serious Infections in Patients With Crohn’s Disease: Secondary Analysis of the PYRAMID Registry. Clinical Gastroenterology and Hepatology. 22(6). 1286–1294.e4. 5 indexed citations
6.
Khalil, Carine, Welmoed K. van Deen, Taylor Dupuy, et al.. (2023). Patients’ Perspectives, Experiences, and Concerns With Perianal Fistulae: Insights From Online Targeted-Disease Forums. Crohn s & Colitis 360. 5(4). otad073–otad073.
7.
Gu, Phillip, Shishir Dube, Yoojin Lee, et al.. (2023). Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn’s Disease (CD). Digestive Diseases and Sciences. 69(1). 235–245. 2 indexed citations
8.
Syal, Gaurav, Miles Sparrow, Fernando Velayos, et al.. (2022). Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology. Digestive Diseases and Sciences. 67(10). 4687–4694. 1 indexed citations
9.
10.
Barnes, Edward L., Laura H. Raffals, Millie D. Long, et al.. (2020). Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States. Crohn s & Colitis 360. 2(3). otaa039–otaa039. 8 indexed citations
11.
Alayo, Quazim A., Wenfei Wang, Alexandra Gutierrez, et al.. (2020). Real-World Effectiveness and Safety of Tofacitinib in Crohn’s Disease and IBD-U: A Multicenter Study From the TROPIC Consortium. Clinical Gastroenterology and Hepatology. 19(10). 2207–2209.e3. 24 indexed citations
12.
Syal, Gaurav, Amir Kashani, Nirupama Bonthala, et al.. (2020). Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis. Digestive Diseases and Sciences. 66(1). 199–205. 19 indexed citations
13.
Alayo, Quazim A., Anish Patel, Gaurav Syal, et al.. (2020). S0897 Efficacy and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases. The American Journal of Gastroenterology. 115(1). S461–S462. 4 indexed citations
14.
Patel, Anish, Parakkal Deepak, Ryan C. Ungaro, et al.. (2019). 796 – Real-World Effectiveness of Tofacitinib in Ulcerative Colitis; a Multi-Center Study. Gastroenterology. 156(6). S–168. 6 indexed citations
15.
Ungaro, Ryan C., Amit Patel, Parakkal Deepak, et al.. (2019). P344 Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study. Journal of Crohn s and Colitis. 13(Supplement_1). S274–S275. 15 indexed citations
16.
Syal, Gaurav, Amir Kashani, & David Q. Shih. (2018). Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists. The American Journal of Medicine. 131(9). 1017–1024. 10 indexed citations
17.
Weaver, Kimberly N., Martin Gregory, Gaurav Syal, et al.. (2018). Ustekinumab Is Effective for the Treatment of Crohn’s Disease of the Pouch in a Multicenter Cohort. Inflammatory Bowel Diseases. 25(4). 767–774. 59 indexed citations
18.
Syal, Gaurav, et al.. (2016). Recurrent Obstructive Giant Inflammatory Polyposis of the Colon. ACG Case Reports Journal. 3(1). e89–e89. 4 indexed citations
19.
Syal, Gaurav, Jagpal S. Klair, & Farshad Aduli. (2015). Leg Swelling and Mildly Deranged Liver Tests: An Unusual Presentation of a Usual Diagnosis. Gastroenterology. 149(2). e10–e11. 1 indexed citations
20.
Syal, Gaurav, Seth Heldenbrand, & Andrés Duarte‐Rojo. (2014). Seizures as a Potential Complication of Treatment With Simeprevir and Sofosbuvir. American Journal of Therapeutics. 23(2). e570–e571. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aušrinė Barakauskienė Breakdown of academic impact, for papers by Timothy E. Ritter Breakdown of academic impact, for papers by Félix Goutorbe Breakdown of academic impact, for papers by Evanthia Zampeli Breakdown of academic impact, for papers by David J. Tsoulis Breakdown of academic impact, for papers by Henna Rautiainen Breakdown of academic impact, for papers by Jill Fennell Breakdown of academic impact, for papers by R. Cosintino Breakdown of academic impact, for papers by G. Van Assche Breakdown of academic impact, for papers by P. Rutgeerts
Rankless by CCL
2026